A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease
NCT05335161 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2025-08-15
Summary
The goal of the proposed pilot study is to evaluate the feasibility of a new leg heat therapy system treatment for patients with lower extremity PAD. The new system is comprised of leg-length water circulating pads surrounded by a separate pneumatic compression outer garment that compresses the pads against the skin for efficient heat transfer. The new leg garment is easily closed with a zipper. The air chambers automatically adjust the amount of air inflation enabling use of the garment independent of patient leg size. Six patients with PAD will be asked to complete daily (90 min/day) home-based leg HT for 12 weeks using the newly developed system. The primary study outcome is the change from baseline in walking performance on the 6-minute walk test at the 12-week follow-up. Secondary outcomes include plantar flexion power, as assessed using isokinetic dynamometry, sit-to-stand muscle power and perceived quality of life.
Conditions
- Peripheral Arterial Disease
- Intermittent Claudication
Interventions
- DEVICE
-
Home-based leg heat therapy
The Aquilo system consists of a garment that contains an inner water-circulating pad that is compressed by air bladders. The volume of air inflating the air bladders is pressure-controlled so the garment automatically adjusts to the shape and size of all legs. The touch screen console contains pre-programmed settings for ease of use. After baseline characteristics are established, patients will be provided with the Aquilo device and will be instructed on how to operate the equipment and how to rapidly remove the system if the alarm sounds or if they have any unusual feeling. Patients in both groups will also receive a logbook to record their sessions. Patients will undergo daily home-based leg HT (90 min/day, 7 days/week) for 12 weeks. Water at 42ºC will be perfused through the water-circulating garment for 90 min, with the goal of increasing skin temperature in the calf to \~37ºC.
Sponsors & Collaborators
-
Aquilo Sports
collaborator UNKNOWN -
Purdue University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-30
- Primary Completion
- 2024-02-07
- Completion
- 2024-02-07
Countries
- United States
Study Locations
More Related Trials
-
Endovascular Treatment of Peripheral Artery Disease (PAD)
NCT03414515 ·Status: COMPLETED
-
Effect of VascuActive Device on Foot Perfusion, Hemodynamics and Exercise Capacity in Patients With PVD & Limb Ischemia
NCT01014377 ·Status: COMPLETED ·Phase: NA
-
PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE
NCT03001700 ·Status: COMPLETED ·Phase: NA
-
Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease
NCT05345431 ·Status: RECRUITING ·Phase: NA
-
Paclitaxel-coated Balloon Angioplasty Versus Standard Angioplasty for the Treatment of Stenosis of Arteriovenous Fistula
NCT02753998 ·Status: COMPLETED ·Phase: PHASE3
-
Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
NCT05450042 ·Status: RECRUITING ·Phase: NA
-
Lower Leg Remote Ischemic Preconditioning in Elective Percutaneous Coronary Intervention (PCI)
NCT01357499 ·Status: WITHDRAWN
-
Study Comparing Legflow Versus Bare Balloon Angioplasty for Treatment of Atherosclerotic Disease
NCT02710656 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of the Device "Nit-Occlud® PDA-R"
NCT01063712 ·Status: COMPLETED ·Phase: PHASE2
-
Online Support for Outpatient Peripheral Arterial Disease Self-management
NCT03464006 ·Status: UNKNOWN ·Phase: NA
-
Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System
NCT03071146 ·Status: COMPLETED
-
Safety and Feasibility of the Shockwave Lithoplasty® System for the Treatment of Peripheral Vascular Stenosis
NCT02911623 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis
NCT01398033 ·Status: WITHDRAWN ·Phase: PHASE3
-
Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02802306 ·Status: COMPLETED ·Phase: NA
-
Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)
NCT02939976 ·Status: TERMINATED ·Phase: NA
-
Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy
NCT02745106 ·Status: UNKNOWN ·Phase: PHASE2
-
Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical Investigation in Infrapopliteal Interventions
NCT03744572 ·Status: COMPLETED
-
Magenta Elevate™ EFS in High-Risk PCI Patients
NCT05727059 ·Status: COMPLETED ·Phase: NA
-
Short-term Perfusion Angiography Pilot Study (SPA)
NCT03054636 ·Status: TERMINATED
-
The PRELUDE BTK Study
NCT03693963 ·Status: COMPLETED ·Phase: NA
-
The Pathway PVD Study for Percutaneous Peripheral Vascular Interventions
NCT00676494 ·Status: COMPLETED ·Phase: NA
-
Microparticles and the Risk of Re-stenosis Following Balloon Angioplasty in Patients With Peripheral Arterial Disease
NCT01422343 ·Status: WITHDRAWN
-
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
NCT07023965 ·Status: ENROLLING_BY_INVITATION
-
Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
NCT01083030 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Feasibility of the ElastiMed's SACS
NCT03330925 ·Status: COMPLETED ·Phase: NA